PFIZER CDR (CAD HEDGED) - stock earnings
PFE.NE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -4.5 billion CAD | 18.9 billion CAD |
| 2023Q3 | -3.2 billion CAD | 18.0 billion CAD |
| 2023Q2 | 3.1 billion CAD | 16.9 billion CAD |
| 2023Q1 | 7.5 billion CAD | 24.7 billion CAD |
| 2022Q4 | 6.8 billion CAD | 32.9 billion CAD |
| 2022Q3 | 11.8 billion CAD | 31.0 billion CAD |
| 2022Q2 | 12.8 billion CAD | 35.8 billion CAD |
| 2022Q1 | 9.8 billion CAD | 32.1 billion CAD |
| 2021Q4 | 4.3 billion CAD | 29.9 billion CAD |
| 2021Q3 | 10.3 billion CAD | 30.5 billion CAD |
| 2021Q2 | 6.9 billion CAD | 23.5 billion CAD |
| 2021Q1 | 6.1 billion CAD | 18.3 billion CAD |
PFE.NE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 2.8 billion CAD | 77.6 billion CAD |
| 2022 | 42.5 billion CAD | 136.0 billion CAD |
| 2021 | 27.8 billion CAD | 102.8 billion CAD |
| 2020 | 12.2 billion CAD | 53.3 billion CAD |
| 2019 | 21.3 billion CAD | 67.6 billion CAD |
| 2018 | 15.2 billion CAD | 73.1 billion CAD |
PFE.NE
Price: CA$13.40
Dividend Yield: 0.13%
Forward Dividend Yield: 8.00%
Payout Ratio: -3538.67%
Dividend Per Share: 1.07 CAD
Earnings Per Share: -0.03 CAD
P/E Ratio: 14.22
Exchange: NEO
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 212.1 billion
Average Dividend Frequency: 4
Years Paying Dividends: 3